A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.

This “SU-GIB” stratification was a highly significant prognostic classifier for both cohorts ( Figure 1 ), independent of confounding factors ( Table 1 ).

also in 132,142 other papers